SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-046587
Filing Date
2023-12-29
Accepted
2023-12-29 16:30:19
Documents
12
Period of Report
2023-12-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39739
  Complete submission text file 0001493152-23-046587.txt   213459

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE imnn-20231229.xsd EX-101.SCH 3009
3 XBRL LABEL FILE imnn-20231229_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE imnn-20231229_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3320
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 231528077
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)